- Home
- NIM vs ATRA Comparison
NIM vs ATRA Comparison
Compare NIM & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NIM | ATRA |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.6M | 94.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | NIM | ATRA |
|---|---|---|
| Price | $8.67 | $9.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | ★ 44.9K | 35.1K |
| Earning Date | 01-01-0001 | 11-11-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,334.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.46 | $3.92 |
| 52 Week High | $9.94 | $19.15 |
Technical Indicators
Market Signals| Indicator | NIM | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 53.48 |
| Support Level | $8.46 | $8.96 |
| Resistance Level | $9.47 | $11.22 |
| Average True Range (ATR) | 0.17 | 0.60 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 41.39 | 67.37 |
Price Performance
Historical ComparisonAbout NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued. The fund has single operating segment.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.